rs7192 — HLA-DRA HLA-DRA Leu242Val

HLA-DRA Leu242Val: The Molecular Gatekeeper of Peanut Antigen Presentation

At the heart of every allergic reaction lies a decision made long before the first exposure: which proteins should the immune system tolerate, and which should trigger a response? That decision is governed by the HLA class II system¹¹ HLA class II system
Human Leukocyte Antigen class II molecules are protein complexes on the surface of antigen-presenting cells that display peptide fragments to CD4+ T cells, shaping immune tolerance vs activation. rs7192 introduces a missense change — Leucine to Valine at codon 242 (Leu242Val) — in the HLA-DRA alpha chain, one of the two protein subunits that form HLA-DR molecules. This single amino acid change alters the structural conformation of the antigen-presenting groove and helps tag HLA class II haplotypes associated with peanut allergy, drug hypersensitivity, and broader immune-mediated conditions.

The Mechanism

HLA-DR molecules are heterodimers — an alpha chain (encoded by HLA-DRA) paired with one of several beta chains (encoded by HLA-DRB1, DRB3, DRB4, or DRB5). The peptide-binding groove formed by the two chains determines which protein fragments the immune system is presented for T-cell education during thymic development and peripheral tolerance maintenance. Leucine 242 sits in the alpha-1 domain²² alpha-1 domain
The membrane-distal domain of the HLA-DRA alpha chain that forms one wall of the peptide-binding groove, a region critical to groove shape and peptide-binding specificity.

The Val substitution introduced by the T allele at rs7192 (the missense G→T change at the DNA level, c.724T>G calling the protein change p.Leu242Val) is predicted to alter alpha-chain conformation. This structural change could shift which peptide fragments are preferentially gripped and displayed to T cells, biasing the early immune response toward sensitization for certain protein antigens — including peanut storage proteins — when the environmental context favors allergic programming over tolerance induction.

Additionally, rs7192 acts as a quantitative trait locus for DNA methylation³³ quantitative trait locus for DNA methylation
A genetic variant that influences how nearby genes are methylated, affecting their expression levels at CpG sites in both HLA-DRB1 and HLA-DQB1. This epigenetic effect — modulating the expression of HLA class II genes beyond just the structural change in the protein — likely amplifies the functional consequence of this variant for antigen-presentation capacity.

The Evidence

Hong et al. (2015)⁴⁴ Hong et al. (2015)
Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children. Nature Communications, 2015 conducted the first GWAS of well-characterised food allergy in 2,197 US participants of European ancestry. rs7192 reached genome-wide significance (p=5.5×10⁻⁸) in the discovery phase and was independently replicated in an additional European cohort. The per-allele odds ratio for peanut allergy was approximately 1.6, placing this SNP among the strongest common genetic risk factors identified for the condition. Crucially, the association was accompanied by genome-wide significant differential DNA methylation at multiple CpG sites within HLA-DQB1 and HLA-DRB1, suggesting that the variant exerts its effect through both protein structural change and epigenetic modulation of HLA class II gene expression.

A complementary line of evidence comes from Guéant et al. (2015)⁵⁵ Guéant et al. (2015)
HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping. Journal of Allergy and Clinical Immunology, 2015, which fine-mapped the HLA-DRA locus in 387 beta-lactam allergy cases and 1,124 controls from Spain (replicated in an Italian cohort). The rs7192 missense variant was significantly associated with allergy to penicillins and amoxicillin (p=7.4×10⁻⁶ discovery; p=6.0×10⁻⁴ replication). The study specifically noted that the variant is "predicted to influence alpha-chain conformation," providing direct functional validation that Leu242Val alters HLA-DRA structure in a clinically meaningful way.

Asai et al. (2018)⁶⁶ Asai et al. (2018)
Canadian peanut allergy GWAS meta-analysis. Journal of Allergy and Clinical Immunology, 2018 integrated data from 8 studies (>7,800 subjects total) and confirmed the HLA-DQB1/ DRB1 region as the primary peanut allergy locus — the same locus tagged by rs7192 and its companion SNP rs9275596. Importantly, the association was independent of asthma genetic architecture, establishing peanut allergy as a genetically distinct trait rather than a subset of atopy.

Practical Actions

The clinical relevance of this variant is clearest in three contexts: peanut allergy risk assessment, early-life peanut introduction for infants, and beta-lactam drug hypersensitivity.

Because rs7192 tags the same HLA risk block as rs9275596 (the primary peanut allergy GWAS signal), the practical implications are closely aligned: individuals carrying one or two T alleles carry a modestly elevated prior probability of peanut allergy through HLA class II-mediated sensitization mechanisms. The landmark LEAP trial showed that early peanut introduction (before 11 months) can completely override this HLA-mediated genetic risk by driving protective IgG4 rather than sensitizing IgE responses. For individuals who have already developed peanut allergy, HLA class II haplotype status predicts superior response to peanut oral immunotherapy — carriers of the risk haplotype achieve higher rates of desensitization than non-carriers.

For drug hypersensitivity, the Leu242Val change confers measurably increased risk for penicillin-class antibiotic allergy. This does not represent a contraindication to penicillin use, but it does mean that any reported penicillin reaction should be taken seriously, formally evaluated, and documented.

Interactions

rs7192 is part of the same HLA-DR/DQ risk block as rs9275596, its companion tag SNP from the peanut allergy GWAS. These two variants operate within the extended HLA class II haplotype architecture spanning chromosome 6p21.32. The HLA region also harbours rs7454108 (tagging HLA-DQ8, associated with celiac disease and type 1 diabetes) and rs2187668 (tagging HLA-DQ2.5, the primary celiac disease haplotype). Together, these tag SNPs define the major HLA class II susceptibility landscape for immune-mediated conditions — a person's full HLA class II profile across these loci provides a more complete picture of their antigen-presentation capabilities than any single SNP alone.